Assessment of Spontaneous Baroreflex Sensitivity in Carriers of Implantable Cardioverter Defibrillators: Association With Disorders of the Ventricular Heart Rate. Case-control Study

Poitiers University Hospital48 enrolled

Overview

We must implement 8 implantable cardioverter defibrillators (ICDs) to save a life in 3 years after myocardial infarction (MI) in primary prevention. Left ventricular ejection fraction (LVEF) is proposed as the one tool predicting sudden cardiac death after MI. Several studies have shown that impairment of spontaneous baroreflex sensitivity (BRS) after MI was predictor of sudden death.

Study Type

INTERVENTIONAL

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Myocardial Infarction

Interventions

Baroreflex assessmentOTHER

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients implanted with an implantable cardioverter defibrillator for primary prevention of of cardiac sudden death, ischaemic cardiomyopathy * Implantable cardioverter defibrillators implantation for at least 3 years * Age ≥ 18 years Exclusion Criteria: * ventricular or atrial pacing ≥1%, * atrial fibrillation history * age under 18 years

Locations (1)

CHU DE Poitiers

Poitiers, France

Outcomes

Primary Outcomes

spontaneous baroreflex sensitivity by the sequence method (mean slope)

Time frame: 10 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.